655 related articles for article (PubMed ID: 32979398)
1. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.
Tsatsakis A; Calina D; Falzone L; Petrakis D; Mitrut R; Siokas V; Pennisi M; Lanza G; Libra M; Doukas SG; Doukas PG; Kavali L; Bukhari A; Gadiparthi C; Vageli DP; Kofteridis DP; Spandidos DA; Paoliello MMB; Aschner M; Docea AO
Food Chem Toxicol; 2020 Dec; 146():111769. PubMed ID: 32979398
[TBL] [Abstract][Full Text] [Related]
2. First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)".
Jakob CEM; Borgmann S; Duygu F; Behrends U; Hower M; Merle U; Friedrichs A; Tometten L; Hanses F; Jung N; Rieg S; Wille K; Grüner B; Klinker H; Gersbacher-Runge N; Hellwig K; Eberwein L; Dolff S; Rauschning D; von Bergwelt-Baildon M; Lanznaster J; Strauß R; Trauth J; de With K; Ruethrich M; Lueck C; Nattermann J; Tscharntke L; Pilgram L; Fuhrmann S; Classen A; Stecher M; Schons M; Spinner C; Vehreschild JJ
Infection; 2021 Feb; 49(1):63-73. PubMed ID: 33001409
[TBL] [Abstract][Full Text] [Related]
3. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
[TBL] [Abstract][Full Text] [Related]
4. Systemic abnormalities in liver disease.
Minemura M; Tajiri K; Shimizu Y
World J Gastroenterol; 2009 Jun; 15(24):2960-74. PubMed ID: 19554648
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19.
Hamouche W; Bisserier M; Brojakowska A; Eskandari A; Fish K; Goukassian DA; Hadri L
J Mol Cell Cardiol; 2021 Apr; 153():72-85. PubMed ID: 33373644
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences.
Jafari Khaljiri H; Jamalkhah M; Amini Harandi A; Pakdaman H; Moradi M; Mowla A
Neurotox Res; 2021 Oct; 39(5):1613-1629. PubMed ID: 34169404
[TBL] [Abstract][Full Text] [Related]
7. COVID-19: Cardio-pulmonary and Vascular Manifestations.
Gawaz M; Scharf RE
Hamostaseologie; 2021 Oct; 41(5):347-348. PubMed ID: 34695851
[TBL] [Abstract][Full Text] [Related]
8. Nervous System Involvement in COVID-19: a Review of the Current Knowledge.
Norouzi M; Miar P; Norouzi S; Nikpour P
Mol Neurobiol; 2021 Jul; 58(7):3561-3574. PubMed ID: 33765290
[TBL] [Abstract][Full Text] [Related]
9. Cross-sectional Imaging Manifestations of Extrapulmonary Involvement in COVID-19 Disease.
Laya BF; Cledera THC; Lim TRU; Baluyut JMP; Medina JMP; Pasia NV
J Comput Assist Tomogr; 2021 Mar-Apr 01; 45(2):253-262. PubMed ID: 33186179
[TBL] [Abstract][Full Text] [Related]
10. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
11. Neurological manifestations of COVID-19, SARS and MERS.
Verstrepen K; Baisier L; De Cauwer H
Acta Neurol Belg; 2020 Oct; 120(5):1051-1060. PubMed ID: 32562214
[TBL] [Abstract][Full Text] [Related]
12. Neurological Involvements of SARS-CoV2 Infection.
Gasmi A; Tippairote T; Mujawdiya PK; Gasmi Benahmed A; Menzel A; Dadar M; Bjørklund G
Mol Neurobiol; 2021 Mar; 58(3):944-949. PubMed ID: 33064267
[TBL] [Abstract][Full Text] [Related]
13. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved.
Carod-Artal FJ
Rev Neurol; 2021 Jun; 72(11):384-396. PubMed ID: 34042167
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics and system biology approaches to identify the diseasome and comorbidities complexities of SARS-CoV-2 infection with the digestive tract disorders.
Nashiry MA; Sumi SS; Sharif Shohan MU; Alyami SA; Azad AKM; Moni MA
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 33993223
[TBL] [Abstract][Full Text] [Related]
15. Extrapulmonary complications of COVID-19: A multisystem disease?
Zheng KI; Feng G; Liu WY; Targher G; Byrne CD; Zheng MH
J Med Virol; 2021 Jan; 93(1):323-335. PubMed ID: 32648973
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal and Hepatic Manifestations of COVID-19: Evolving Recognition and Need for Increased Understanding in Vulnerable Populations.
Garland V; Kumar AB; Borum ML
J Natl Med Assoc; 2021 Apr; 113(2):142-146. PubMed ID: 32807512
[TBL] [Abstract][Full Text] [Related]
17. Neurological manifestations and comorbidity associated with COVID-19: an overview.
Kumar M; Thakur AK
Neurol Sci; 2020 Dec; 41(12):3409-3418. PubMed ID: 33052573
[TBL] [Abstract][Full Text] [Related]
18. COVID-19's Clinical-Pathological Evidence in Relation to Its Repercussion on the Central and Peripheral Nervous System.
Morgado AM; Bezerra ALMS; Felix EBG; Júnior JCS; Pinto NB; Neto MLR; de Aguiar Rocha Martin AL
Adv Exp Med Biol; 2021; 1353():197-215. PubMed ID: 35137375
[TBL] [Abstract][Full Text] [Related]
19. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.
Bostancıklıoğlu M
Inflamm Bowel Dis; 2020 Jul; 26(8):e89-e91. PubMed ID: 32440692
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis and management of myocardial injury in coronavirus disease 2019.
Wei ZY; Geng YJ; Huang J; Qian HY
Eur J Heart Fail; 2020 Nov; 22(11):1994-2006. PubMed ID: 32683753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
